Argent BioPharma Ltd.

argentbiopharma.com

Formerly MGC Pharmaceuticals

High-Tech Company
Public Company

(LSE: MXC), (ASX: MXC)

TECH VERTICALS

Biologicals, Biotechnology, Life Sciences, Medical Cannabis, MedTech, Pharmaceuticals

General Data

Sector	Biomed
Company Stage:	R&D
Established	2015
Number of Employees	24
Employees in Israel	5

DESCRIPTION

Argent BioPharma is a specialized Biopharmaceutical company focused on developing and marketing innovative drugs. Utilizing advanced nanotechnology and a multidisciplinary approach in its in-house R&D platform to develop innovative therapies. This approach mainly targets the central nervous system (CNS) and the Autoimmune System.

TECHNOLOGY

Cannabidiol - CBD - is a cannabis compound that has significant medical benefits, but does not have the Psychoactivity of THC. CBD is considered to have a wider scope of medical applications than tetrahydrocannabinol (THC), and with more appealing treatment options for patients seeking anti-inflammatory, anti-pain, anti-anxiety, anti-psychotic, and/or anti-spasm effects without any psychoactive effects.

Products and Phases

Product	Phase
CannEpil®	Approved Phase II
Refractory epilepsy seizure control treatment.
CimetrA®	Phase III
Acute Lung Injury and ARDS
CogniCann®	Phase II
CogniCann® designed as a treatment for the symptoms associated with Dementia and Alzheimer’s.

	TARGET MARKETS
	Medical cannabis patients

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: London, United Kingdom

Address	25 Eccleston Place
City	London
Country	United Kingdom
Zip	SW1W 9NF

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Perth, Australia

Address	295 Rokeby Rd.
City	Perth
Country	Australia
Zip	WA 6008

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Igor Bluvstein	CFO & COO	G Medical (CFO)
Mr. Amir Polak	Chief Pharma Development Officer	KLAD (VP International Sales & Development)
Ms. Sabina Suljakovic	Chief Quality & Commercial Officer
Mr. Yair Tal	CISO
Mr. Jonathan Grunfeld	Chief Medical Officer
Mr. Nativ Segev	Co-Founder	Better (CEO)
Mr. Roby Zomer	Co-Founder	Green City (Director of Business Development & Co-Founder)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Co-Founder, Argent BioPharma Ltd.

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Reverse Merger

Apr. 28, 2016

R&D

abCDe

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Feb. 09, 2021	Listing	LSE	abCDe	abCDe

Last Updated:	abCDe
IVC Number:	abCDe